Stephen Chen - QuinStreet Senior President
| QNST Stock | USD 18.26 0.10 0.55% |
President
Stephen Chen is Senior President of QuinStreet
| Age | 39 |
| Address | 950 Tower Lane, Foster City, CA, United States, 94404 |
| Phone | 650 587 7700 |
| Web | https://www.quinstreet.com |
Stephen Chen Latest Insider Activity
Tracking and analyzing the buying and selling activities of Stephen Chen against QuinStreet stock is an integral part of due diligence when investing in QuinStreet. Stephen Chen insider activity provides valuable insight into whether QuinStreet is net buyers or sellers over its current business cycle. Note, QuinStreet insiders must abide by specific rules, including filing SEC forms every time they buy or sell QuinStreet'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Stephen Chen over a month ago Disposition of 1331 shares by Stephen Chen of Duolingo at 14.42 subject to Rule 16b-3 | ||
Stephen Chen over three months ago Disposition of 275 shares by Stephen Chen of Duolingo at 307.0355 subject to Rule 16b-3 |
QuinStreet Management Efficiency
Return On Tangible Assets is likely to gain to -0.17 in 2025. Return On Capital Employed is likely to drop to -0.13 in 2025. Non Current Liabilities Total is likely to gain to about 36.9 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 82.1 M in 2025. QuinStreet's management efficiency ratios could be used to measure how well QuinStreet manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 12 records | PRESIDENT Age | ||
| Jonathan Bendheim | Phibro Animal Health | 49 | |
| Ramon Fuenmayor | Phibro Animal Health | N/A | |
| Samson Li | Phibro Animal Health | 53 | |
| Thomas Dagger | Phibro Animal Health | 66 | |
| Daniel Bendheim | Phibro Animal Health | 52 | |
| Lisa Escudero | Phibro Animal Health | 63 | |
| Rebecca Kitchens | TechTarget, Common Stock | 46 | |
| John Swenson | NMI Holdings | N/A | |
| Rob Aukerman | Phibro Animal Health | 67 | |
| Michael Giambalvo | Phibro Animal Health | N/A | |
| Adam Pollitzer | NMI Holdings | 45 | |
| Bill Morelli | TechTarget, Common Stock | N/A | |
Management Performance
| Return On Equity | -0.0552 | ||||
| Return On Asset | 0.0031 |
QuinStreet Leadership Team
Elected by the shareholders, the QuinStreet's board of directors comprises two types of representatives: QuinStreet inside directors who are chosen from within the company, and outside directors, selected externally and held independent of QuinStreet. The board's role is to monitor QuinStreet's management team and ensure that shareholders' interests are well served. QuinStreet's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, QuinStreet's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Douglas Valenti, President Chairman | ||
| Peter Brooks, Senior President | ||
| Nina Bhanap, CTO and President of Product and Technology | ||
| Stephen Chen, Senior President | ||
| Robert Amparo, Senior Finance | ||
| Martin JD, Chief Officer | ||
| Gregory Wong, CFO and Sr. VP | ||
| Martin Collins, Chief Compliance Officer, Head of Corporate Devel., Sr. VP and General Counsel | ||
| Ashley Heller, Chief Officer | ||
| Jeremy Crisp, Senior Marketing | ||
| Timothy JD, Chief Officer | ||
| Hayden Blair, Sr Relations |
QuinStreet Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is QuinStreet a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0552 | ||||
| Return On Asset | 0.0031 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 974.19 M | ||||
| Shares Outstanding | 56.47 M | ||||
| Shares Owned By Insiders | 4.22 % | ||||
| Shares Owned By Institutions | 93.90 % | ||||
| Number Of Shares Shorted | 1.36 M | ||||
| Price To Earning | 24.39 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for QuinStreet Stock Analysis
When running QuinStreet's price analysis, check to measure QuinStreet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy QuinStreet is operating at the current time. Most of QuinStreet's value examination focuses on studying past and present price action to predict the probability of QuinStreet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move QuinStreet's price. Additionally, you may evaluate how the addition of QuinStreet to your portfolios can decrease your overall portfolio volatility.